C-Peptide Index may Predict endogenous insulin secretory capacity under non-fasting conditions: Study Dr Riya Dave4 May 2024 10:00 AM ISTResearchers have found that the C-peptide index (CPI) at 2 hours post-meal is a significant indicator of endogenous insulin secretory capacity in...
Medical Bulletin 17/November/2023 Isra Zaman17 Nov 2023 3:00 PM ISTHere are the top medical news of the day:Weight loss within first 2 years of treating type 2 diabetes associated with remissionWeight loss within the...
Weight loss within first 2 years of treating type 2 diabetes associated with remission Isra Zaman17 Nov 2023 9:00 AM ISTResearchers used the health examination database of the Korean National Health Insurance Service. Patients diagnosed with type 2 diabetes mellitus...
GLP-1 receptor agonist therapy has CV benefits in type 2 DM, shows survival time analysis Dr. Hiral patel1 Jun 2022 9:30 AM ISTUSA: Glucagon-like peptide (GLP)-1 receptor agonists may delay the incidence of major adverse cardiovascular events (MACE) Glucagon-like peptide...
Treatment of GDM with Metformin tied to Favourable Lipid Profile in Offsprings MD Bureau16 Nov 2021 10:00 AM ISTGestational diabetes mellitus (GDM) is a complication in about 5% of pregnancies, is increasing in prevalence, and is associated with complications to...
Liraglutide as add-on to insulin therapy reduces BMI, added sugar intake in obese type 1 diabetes patients: Study Medha Baranwal16 Oct 2021 9:00 AM ISTDenmark: According to a recent study in the journal Diabetes, Obesity & Metabolism, the addition of liraglutide lowered fat and lean body mass in...
High-dose SGLT2 inhibitors tied to superior blood sugar control in type 2 diabetes: Study Medha Baranwal21 Jun 2021 11:44 AM ISTChina: The use of clinically approved high-dose SGLT2 inhibitors may help in improving blood sugar levels, body weight and blood pressure in patients...
Intermittent intensive insulin therapy may not help preserve beta-cell function in diabetes: Study Medha Baranwal8 Jun 2021 9:15 AM ISTCanada: Intermittent intensive insulin therapy (IIT) is not feasible as a long-term strategy for preserving the function of beta-cell in early type 2...
Exenatide-Dapagliflozin Combo Enhances Kidney Protection: DECREASE Trial Dr Kartikeya Kohli24 May 2021 7:30 PM ISTSodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1RAs) are common hypoglycemic drugs. Previous...
Metformin effectively controls blood sugar in diabetics With moderate CKD: Study Medha Baranwal20 May 2021 11:30 AM ISTUSA: Blood sugar control is essential to delay or prevent the onset of diabetic kidney disease. There are a number of glucose-lowering medications...
High-protein diet plan tied to lower blood sugar variability in Type 1 diabetes: Study Dr Satabdi Saha12 May 2021 11:30 AM ISTCompared with a 'standard' or 'reference' diet and a Mediterranean style diet (MED), a high-protein/low-carbohydrate diet (HPD) plan may have a...
Henagliflozin, Metformin combo effective Option for Diabetics Nonresponsive to Metformin Dr Kartikeya Kohli30 March 2021 8:10 AM ISTTreatment of type 2 diabetes often begins with lifestyle management and/or metformin. As beta-cell function declines in the presence of insulin...
